News & Views

Eagle Genomics expansion grows

Bioinformatics software pioneer for the life sciences arena Eagle Genomics (www.eaglegenomics.com) expands its global team with the appointment of bioinformatics veteran Dr. Nandu Gattu as VP Services, Dr. Christian Roghi as Director of Microbiome Solutions, and Louise Groves as Director of Business Operations.

Joining Eagle Genomics’ rapidly growing Indian operations, Dr. Nandu Gattu has over 25 years’ experience in computational biology and data science working with global pharma companies including Schering Plough, SmithKlineBeecham, and GSK.  Dr. Gattu has a Ph.D. in Neuropharmacology from the Medical College of Georgia, USA, a MS in Cardiovascular Pharmacology from the University of Montana, USA, and a Degree in Ayurvedic Medicine from Osmania University, India.   With several scientific publications and 50+ patents to his name, Dr. Gattu was previously Adjunct Professor at Deakin University, Australia.

Dr. Christian Roghi, whose recent career has spanned the food and pharma science sectors, will help guide Eagle Genomics’ commercial focus on the microbiome.  Dr. Roghi has extensive experience in cancer research, after spending two decades deciphering key processes controlling tumor progression in French, German, US and UK laboratories.  He has authored numerous peer-reviewed scientific publications.  In addition to a MSc in Biochemistry and a Ph.D. in Biological Sciences from the University of Rennes, France, Christian has an Executive MBA and a Diploma in Management Consultancy from Norwich Business School.

Louise Groves joins the team as Director, Business Operations as part of Strategy & Operations.  Her 25-year career to date spans senior Informatics, Program Management, and Chief of Staff roles in global biopharma companies including Roche, GSK and Pfizer.

Commenting on the appointments Anthony Finbow, CEO, Eagle Genomics, says “We’ve been delighted to kick off 2022 with these three high-profile appointments that reflect very well our ambitions for this year and beyond.  As all kinds of companies turn to the natural world as the basis for next-generation bio-inspired innovation, Eagle Genomics is experiencing robust and growing demand from global organizations.  This includes the support of research and development in critical areas like the microbiome, with our AI-augmented knowledge discovery platform e[datascientist]™. With our strong and growing team, we are focused on unlocking the economic opportunities of the Bio Revolution while helping tackle the world’s Grand Challenges.”

Last year, Eagle Genomics announced the opening of its innovation hub at Laxmi Cyber City, Hyderabad in India.  Commenting on the opening, UK Prime Minister Boris Johnson said, “I’m delighted that Eagle Genomics is expanding into India to make the most of the opportunities for UK businesses in one of the world’s biggest economies.  Our exporters are brilliant ambassadors for Britain, and I hope today’s announcement is just the start of what you can do for India and the UK.”